Skip to content

Usefulness of Homoeopathic medicines in treating the Substance-Induced Psychotic Disorder

Effectiveness of Individualized Homoeopathic Medicines in the management of Substance-Induced Psychotic Disorder – An Open-Label Single-Arm Study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073432
Enrollment
35
Registered
2024-09-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F10-F19- Mental and behavioral disorders due to psychoactive substance use

Interventions

Intervention1: Individualized Homoeopathic Medicines: Individualized Homoeopathic Medicine potency ranging from 30C to 50M in the form of uniform-sized medicated globules will be administered orally a

Sponsors

Dr M Selvaganapathi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of both genders between the ages of 18 to 60. 2. Patients presenting with Psychotic symptoms due to substance use. 3. BPRS score of 18 or more.

Exclusion criteria

Exclusion criteria: 1. Suicidal ideation. 2. Life-threatening serious systemic illness. 3. Pregnant and lactating women. 4. Primary psychotic disorders. 5. Psychotic disorder due to another medical condition.

Design outcomes

Primary

MeasureTime frame
Assessment of the reduction of the severity of symptoms of participants with substance-induced psychotic disorder after the administration of Individualized Homoeopathic Medicines is planned to be done using the Brief Psychiatric Rating Scale (BPRS).Timepoint: Every month from baseline till the 9th month

Secondary

MeasureTime frame
Assessment of the changes in quality of life of participants with substance-induced psychotic disorder after the administration of Individualized Homoeopathic Medicines is planned to be done using the World Health Organization Quality of Life (WHO-BREF-QoL) scale.Timepoint: At the baseline & at the 9th month

Countries

India

Contacts

Public ContactDr S Karunakaramoorthi

National Homoeopathy Research Institute in Mental Health, Kottayam

selvaganapathimaddy@gmail.com8667461149

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026